Marc Stad’s Maravai LifeSciences MRVI Stock Holding History

Marc Stad’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-750,468	Closed	-$5.37M	–	28
2024 Q2	$5.37M	Buy	+750,468	New	+$6.48M	0.1%	28

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return

1WCM

12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Marc Stad's MRVI Position: Q3 2024 in Review

Marc Stad sold out of Maravai LifeSciences (MRVI) in Q3 2024, closing a stake of 750,468 shares — an estimated $5.37M sold.

Marc Stad first reported a position in MRVI in Q2 2024 and held it in 1 quarter. The position peaked at $5.37M in Q2 2024. 217 funds tracked by Wall St. Rank hold MRVI as of Q3 2024.

Marc Stad reported no remaining Maravai LifeSciences position as of Q3 2024 after selling out during the quarter.
Marc Stad sold 750,468 Maravai LifeSciences shares in Q3 2024, an estimated $5.37M.
Marc Stad first reported a position in Maravai LifeSciences in Q2 2024 and held it in 1 quarter.
Marc Stad's Maravai LifeSciences position peaked at $5.37M in Q2 2024.
217 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2024.

Based on Dragoneer Investment Group's 13F filing for Q3 2024, filed 14 Nov 2024.